I think I see another late reported trade... A suspected buy of over £500k from yesterday. Feels like a hugely significant day yesterday in terms of volume and II involvement.
Lots of activity indeed. Spreadex were below 3% but will be interesting to see if any holding notifications next week. Hopefully a path cleared for an overdue and sustained rise.
So should be a buy.. yet no impact on SP as I write... but encouraging sign.
Thanks to Mafuta re Caitlin contact. I have emailed.
all best for Christmas and new year. Stay safe all
Parked some cash in the Shed yesterday after keeping an eye on for months. In line with the Hard man report this month, can only see this going higher. With decent dividends too this seems a massively overlooked stock to me especially with the current acquisitions going on. I look forward to next set of results with confidence. Gla
This feels like Fomo and people taking positions in case of positive covid treatment news. While positive news would of course be great... Not least because we might already have saved lives, there would still be some way to go to commercialisation. Frankly though it's nice to be in a share where that is my secondary concern.
A positive result would also be fab news for use in other respiratory failure events presenting similar conditions. Gla
A little more proactivity would help.. Last twitter update January. Website currently blocked by my browser as unsafe.. Hmm. Not great is it. No interviews with new chief executive. No news from US expansion. Frustrating attitude. Is there an investor relations contacy at the company. I will make contact if someone can identify. Anyhow... A nice January update would be welcome.
I think this company has great products and prospects. but given they are in sales, they need to be more vocal
been off the bbs for a few weeks...what did I miss lol.
I was planning to use the 'Hope' subject thread...Don't tell me even that's gone now ha.
I might just come back in a couple more weeks. As long as we are still digging up a load of copper we should be ok in the longer run.
Personally I too suspect an II selling down..Hopefully Spreadex clearing out as expected,. Under 3% hence may not be a TR1.
absolutely..I had to top up here this morning.
A couple of days of rising SP would do absolute wonders here. It may well happen as we approach the 15th, in anticipation. A word of caution that the wording of the last finance RNS did not say that we will know then, but there is a ratification meeting that day. We may need to wait for a letter from the bank subsequently. Hopefully not. Or if agreed as expected we can get the heads up.
Great post. I concur.
Today's another day producing a load of copper and other metals from a huge mine in a safe jurisdiction. Something in the region of 20 tonnes of concentrate per day. Should be a very happy time to be involved here. Finance crossing t's and dotting i's in less than 2 weeks enabling consolidation and then expansion at Baita Plai and elsewhere. Looking forward to brighter times here for all shareholders, which notably includes our CEO.
The Brazil trial is P2... Only 60 patients. So P3 would follow which they would expedite, and no time frame given... But I'd anticipate circa 6 to 8 months.
Re Accustem, they said not able to suggest price yet
Shocking Bod engagement guys. No interviews, press, shareholder chats. Hope to see that change with the forward plan. Gla
TheMorg. Glad you raised NDAs.
As I see it until they do further clinical trials they don't have any extra data on Foralumab so the 5 long-standing NDAs cannot relate to effectiveness, and the Brazil trial is not relevant to the NDAs which were in place a while back. We have been told they also don't relate to ACCUSTEM (sale?).
So would be very interested in any views on what sort of thing they might relate to. It has puzzled me since I first took up some shares here. Has anyone experience of similar stocks and NDAs which might provide some clues?
I wonder if any of the NDAs relate to the licensing agreements for the drug portfolio, but that's only one potential.
So, over to others as would be very interested in views. all best
MRK
anyone got a study protocol?
4 weeks and counting for the brazil study - first dose was on the 3rd november.
2 or 4 week follow up likely.
Results by end of year.
Anyways.
Worth reiterating the main news headlines today...easily lost in the 'banter'.
1: Asset based finance deal to be finalised between Vast and Tier 1 Bank, and presented to the Bank’s credit committee for final approval in a meeting scheduled for 15 December 2020.
That's it really. But it's very good, and in line with the expected timeline shared by the BoD. Long may that continue. Nighty night.
Large trade of £41K at close there, while copper is up 3% to 7500+ (as I write). https://markets.businessinsider.com/commodities/copper-price
there is indeed a lot of baggage, but also a lot of bags of copper.
Bezzy.
Yeah, just happy for them to keep mining at present.
Should only be good news ahead - next delivery, finance, production ramp up etc, but happy for things to tick over while we wait. Fingers crossed, no bad news in next period and we can move on towards profitability. GLA